疏肝解郁胶囊与氟西汀治疗产后抑郁症的效果对比
2014-09-25张保健等
张保健等
[摘要] 目的 观察疏肝解郁胶囊治疗产后抑郁症的临床效果及安全性。 方法 将96例产后抑郁症患者随机分为研究组(n=48)和对照组(n=48),研究组口服疏肝解郁胶囊,对照组采用氟西汀进行治疗,采用汉密尔顿抑郁量表(HAMD)、副反应量表(TESS)评定疗效及不良反应。 结果 研究组有效率为87.5%,对照组有效率为89.6%,差异无统计学意义(P>0.05);两组治疗后HAMD评分均较治疗前显著下降(P<0.01),但两组间评分差异无统计学意义(P>0.05);研究组TESS评分显著低于对照组(P<0.05),研究组失眠发生率明显低于对照组(P<0.01)。 结论 疏肝解郁胶囊治疗产后抑郁症疗效与氟西汀相当,且不良反应明显少于氟西汀。
[关键词] 疏肝解郁胶囊;氟西汀;产后抑郁症
[中图分类号] R971 [文献标识码] A [文章编号] 1674-4721(2014)08(b)-0134-03
[Abstract] Objective To observe the clinical curative effect of Shuganjieyu capsule in the treatment of postpartum depression. Methods 96 cases of patients with postpartum depression were randomly divided into research group (n=48) and control group (n=48),research group were given with Shuganjieyu capsule,control group were given with fluoxetine.The curative effects were assessed with Hamilton depression scale (HAMD,17-item),the adverse reactions were assessed with treatment emergent symptom scale (TESS). Results The effective rate of research group was 87.5%,the control group was 89.6%,the difference was not significant (P>0.05).After treatment,the scores of HAMD in both groups were significantly decreased compared with before treatment (P<0.01),but there was no significant difference between the two groups (P>0.05).The scores of TESS in research group was lower than that in control group (P<0.05),the incidence of insomnia in research group was lower than that in control group (P<0.01). Conclusion The efficacy of Shuganjieyu capsule is similar to fluoxetine in the treatment of postpartum depression.The adverse reactions of Shuganjieyu capsule is lower than than flouxetine.
[Key words] Shuganjieyu capsule;Fluoxetine;Postpartum depression
产后抑郁症是指产妇在分娩后6周内出现的以情绪低落、悲伤哭泣、兴趣减退、精力下降,易激动、烦躁,重者出现自责自罪或自杀等症状为特征的一种重型情感障碍,不仅影响产妇的身心健康及婚姻家庭,还影响哺乳及母婴关系[1-4],其治疗的1周显效和4~6周才显效患者的痊愈率分别为60%~70%和20%左右[5],加之产后妇女身体功能发生明显变化,对药物的耐受性降低,产后抑郁症的治疗往往依从性较差,因此早期发现并应用安全、有效、依从性好的药物治疗产后抑郁症尤为必要。中成药在我国应用普遍,依从性好。疏肝解郁胶囊是国内第一个批准用于治疗轻中度抑郁症的复方中成药,具有比较确切的抗抑郁作用。本研究以氟西汀为对照,观察疏肝解郁胶囊治疗产后抑郁症的疗效及安全性。
1 资料与方法
1.1 一般资料
所有病例均为2011年8月~2013年12月住本院符合国际精神病分类与诊断标准(ICD-10)抑郁症诊断标准的患者。符合……
